Sree Rayalaseema Hi-Strength Hypo DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.74×0.75×0.73×0.74×0.81×
1.48×1.49×1.41×1.07×1.20×
11.9%12.2%13.3%11.5%9.6%
0.61×0.61×0.64×0.95×1.93×
1.13×1.13×1.15×1.14×1.23×
9.1%9.3%10.1%9.8%22.2%
9.5%9.5%10.2%10.2%23.4%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SRHHYPOLTD₹499.15

Sree Rayalaseema Hi-Strength Hypo Limited

· Chemicals
₹ CrorePeersGEMAROMADMCCSUDARCOLORJAYAGROGNKRONOXAMNPLSTCHEMFABPRIMOMcap ₹857 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.810.740.730.750.74
Interest Burden (Pretax/EBIT) ×1.201.071.411.491.48
EBIT Margin %9.6011.5413.2812.1811.92
Asset Turnover ×1.930.950.640.610.61
Financial Leverage (Assets/Equity) ×1.231.141.151.131.13
ROE (5-step product, year-end total equity) %22.189.8410.069.349.10
ROE (owners' profit / average owners' equity) %23.3510.1810.179.549.54
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.